Overall, these results uncovered a novel role of podocyte RIPK3 in promoting podocyte injury and DKD progression by regulating NF‐κB‐mediated inflammatory signaling independent of necroptosis, offering novel insights and potential therapeutic strategies for DKD management. The gene discussed is NFKB1; the disease is diabetic kidney disease.